GLP-1 drugs like Ozempic and Wegovy have transformed conversations around weight loss and metabolic health — but are we witnessing a medical breakthrough or participating in a massive social experiment?
In this episode, we explore how these FDA-approved drugs moved from diabetes treatment to mainstream use for weight management, reshaping medicine, ethics, and culture along the way. We discuss how science identifies new uses for existing drugs, what we’ve learned from past off-label revolutions, and why GLP-1s may be testing not just our metabolism, but our trust in modern medicine itself.
Topics include:
How GLP-1 receptor agonists work in the brain and body
Why appetite, reward, and dopamine matter
The balance between scientific discovery and real-world experimentation
What this moment reveals about how we use (and market) medicine today
Available on all streaming platforms — just search “Gopu & Zane” or visit lybrandlab.org/jospod
Podden och tillhörande omslagsbild på den här sidan tillhör
Gopu and Zane. Innehållet i podden är skapat av Gopu and Zane och inte av,
eller tillsammans med, Poddtoppen.
